The Advisory Board Team at Immunic Therapeutics provides strategic guidance and expertise to support the development and advancement of the company's selective oral immunology therapies. Comprising members from the scientific-medical and business sectors, along with executive leadership, the team ensures informed decision-making and alignment with industry standards to optimize clinical outcomes and business growth.
Barclay A. Philipps
Lead Independant Director
Dr. Bruce E. Sands
Member of the Scientific-Medic...
Dr. Daniel Vitt
CEO & President
Dr. Fred D. Lublin
Member of the Scientific-Medic...
Dr. Hella Kohlhof
CSO
Dr. Joerg Neermann
Member of the Board of Directo...
Dr. Manfred Groeppel
COO
Dr. Vincent Ossipow
Member of the Board of Directo...
Glenn Whaley
Vice President Finance, Princi...
Tamar Howson
Member of the Board of Directo...
View all